Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma

Multiple myeloma remains an incurable disease despite the introduction of the immunomodulatory drugs (IMiDs) thalidomide and lenalidomide and the proteasome inhibitor bortezomib that have improved the outcome of patients with both newly diagnosed and relapsed/refractory disease. However, patients wh...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Terpos, Evangelos, Kanellias, Nikolaos, Christoulas, Dimitrios, Kastritis, Efstathios, Dimopoulos, Meletios A
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2013
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3656921/
https://ncbi.nlm.nih.gov/pubmed/23690693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S34498
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk